Miguel Ángel Ávila

Chief Executive Officer

Miguel Ángel is an Engineer and R&D manager with GESTIDI certification. He has previously managed and coordinated 25 national and 4 FP7 projects at R&D companies such as Oblanca (Spain). He was also the founder of Spanish companies Thermolabel Technology and La Era, which were successfully exited.

Cláudio Santos

Chief Business Officer

Cláudio has a BSc and PhD in Biology. Previously he worked as a Technology Transfer Manager at Cancer Research Technology (UK), as a life sciences venture capital investor at Sixth Element Capital (UK) and as Chief Business Officer at Bioncotech Therapeutics (Spain).

Álvaro Sanz

Manager (“CFO”)

Álvaro is a graduate in Business Administration with over 20 years of experience in SME business administration. He has a track record of leading M&A operations. At Neurofix, he is responsible for administration, financial control and accountancy.

Daniel Bermejo

Clinical Trial Coordinator

Daniel is a BSc and MRes in Biology with extensive experience in data and project management and in clinical development gained at Spanish companies such as Farmalider Group, Fina Biotech, PharmaMar and Sermes.

Dr. Ignácio Galicia

Clinical Advisor

Ignácio is an MD and Clinical Pharmacologist, who is currently the Director of Clinical Research at Institute Fundación Teófilo Hernando (Madrid, Spain). Previously, he was the leader of Clinical Research at Hospital La Paz (Madrid, Spain) and the Director of the Clinical Trial Unit at Hospital Gómez Ulla (Madrid, Spain).

Professor Pablo Escribá

Scientific Advisor

Pablo is a Professor at the University of Illes Balears. He has over 30 years of biomedical research experience and is the author of 6 patents licenced to biotech companies and over 100 scientific publications.